Evidence map›Paper›PMID 38835539›Full record

ArticleBMJ neurology open2024

Evaluation of an ambulatory care pathway for patients with nitrous oxide-induced myeloneuropathy.

Safiya A Zaloum, Alvar Paris, Devan Mair, Charles Gutteridge, Ruth M Ayling, Barbara L Onen, Joseph Walton, Anna Workman, Nelia Villanueva, Alastair J Noyce

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ neurology open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Safiya A ZaloumCentre for Preventive Neurology, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK.ORCID 0009-0000-4772-5162
Alvar ParisCentre for Preventive Neurology, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK.
Devan MairCentre for Preventive Neurology, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK.
Charles GutteridgeBarts Health NHS Trust, London, UK.
Ruth M AylingBarts Health NHS Trust, London, UK.
Barbara L OnenBarts Health NHS Trust, London, UK.
Joseph WaltonBarts Health NHS Trust, London, UK.
Anna WorkmanBarts Health NHS Trust, London, UK.
Nelia VillanuevaBarts Health NHS Trust, London, UK.
Alastair J NoyceCentre for Preventive Neurology, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Cases of nitrous oxide (N Methods: Patients on the N Results: 35/56 (62.5%) patients were discharged from ambulatory care due to non-attendance and 17/56 (30.4%) completed their treatment course. The median time from initial presentation to discharge was 49 days. 24/40 (60.0%) of patients with a final neurological examination documented had a residual deficit, with objective sensory deficits most common. 12 patients were approached to receive weekly questionnaires via WhatsApp. 5/8 who expressed interest returned a consent form. All participants were withdrawn due to non-response or participant choice. 1/5 returned more than two surveys. Conclusion: Despite poor participation in surveys delivered via WhatsApp, novel approaches are needed to improve engagement with patients on the N

Indexed as

B12 DEFICIENCYCLINICAL NEUROLOGYMEDICINEMYELOPATHY

Identifiers

PMID38835539
PMCPMC11149123

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.